ResMed Inc (RSMDF) stock
RSMDFOTCSurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RMD
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026Score 21/3011% below fair value
$22.61+0.00 (0.00%)
Close on Oct 19, 2026Market cap $33.17BP/E 22.0Yield 1.04%
ResMed price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
ResMed's price to sales ratio was 6.1× on Oct 19, 2026, against 7.0× a year earlier. Over the last 5 years it ranged from 4.9× to 11.3×, with a median of 7.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 6.1× | −0.6 |
| 2025 | Dec 31, 2025 | 6.7× | −0.3 |
| 2024 | Dec 31, 2024 | 7.0× | +1.2 |
| 2023 | Dec 29, 2023 | 5.8× | −2.6 |
| 2022 | Dec 30, 2022 | 8.4× | −2.9 |
| 2021 | Dec 31, 2021 | 11.3× | +1.2 |
| 2020 | Dec 31, 2020 | 10.2× | +1.9 |
| 2019 | Dec 31, 2019 | 8.3× | +1.5 |
| 2018 | Dec 31, 2018 | 6.7× | +1.1 |
| 2017 | Dec 29, 2017 | 5.7× | +1.1 |
| 2016 | Dec 30, 2016 | 4.6× | +0.2 |
| 2015 | Dec 31, 2015 | 4.4× | −0.6 |
| 2014 | Dec 31, 2014 | 5.0× | +0.6 |
| 2013 | Dec 31, 2013 | 4.4× | +0.1 |
| 2012 | Dec 31, 2012 | 4.3× | +1.3 |
| 2011 | Dec 30, 2011 | 2.9× | −1.7 |
| 2010 | Dec 31, 2010 | 4.7× | +0.3 |
| 2009 | Dec 31, 2009 | 4.4× | – |